文献速递前列腺癌

前列腺癌当代分级系统中三级Gleason模式5的预后作用

The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2016-11-15

该研究回顾性分析了2005至2014年在本机构接受根治性前列腺切除术的1396例局限性Gleason评分6-8分前列腺癌患者,最终纳入1229例。在732例Gleason评分7分患者中,75例(10.2%)存在三级Gleason模式5,其生化复发无生存率显著更差(P<0.001),多因素Cox回归显示三级Gleason模式5是生化复发的显著预测因子(风险比1.750,P=0.027)。在新分级系统下,伴三级Gleason模式5的2级患者生化复发风险与3级相当,伴三级Gleason模式5的3级患者表现类似4级。

要点

  • 在Gleason评分7分前列腺癌中,三级Gleason模式5是生化复发的显著预测因子(风险比1.750,P=0.027)。
  • 伴三级Gleason模式5的Gleason评分7分患者,其生化复发风险在新分级系统下相当于升高一个级别。
  • 作者认为应将三级Gleason模式5纳入Gleason评分7分以辅助未来风险评估和随访安排。

核心结论

  • 本研究表明,三级Gleason模式5增加Gleason评分7分前列腺癌患者根治性前列腺切除术后的生化复发风险。
  • 在新分级系统下,Gleason评分7分中存在三级Gleason模式5使生化复发风险升高至与下一个更高级别相当。
  • 这些发现支持将三级Gleason模式5纳入Gleason评分7分,以辅助未来风险评估和随访安排。

研究设计与样本

  • 回顾性队列研究,回顾本机构2005年至2014年接受根治性前列腺切除术的1396例局限性Gleason评分6-8分(pT2-3N0M0)前列腺癌患者记录。
  • 排除接受新辅助或辅助治疗、病理或随访数据不完整的患者后,最终分析纳入1229例。
  • 采用Kaplan-Meier法估计和比较生化复发概率,Cox回归模型分析变量与生化复发风险的关联。

主要发现

  • 732例Gleason评分7分患者中,75例(10.2%)存在三级Gleason模式5。
  • 伴三级Gleason模式5患者的生化复发无生存率显著差于不伴三级Gleason模式5者(P<0.001)。
  • Gleason评分7分前列腺癌的多因素Cox回归分析中,三级Gleason模式5是生化复发的显著预测因子(风险比1.750,P=0.027)。
  • 按新分类将总队列分为四个级别组后,伴三级Gleason模式5的2级患者生化复发风险与3级相当,伴三级Gleason模式5的3级患者表现类似4级。

临床怎么用

  • 作者认为应将三级Gleason模式5纳入Gleason评分7分,以辅助未来风险评估和随访安排。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently, a new prostate cancer (PC) grading system has been introduced, where Gleason score (GS) 7 (3+4) and GS 7 (4+3) are categorized into two separate groups. However, GS 7 with tertiary Gleason pattern 5 (TGP5) was not incorporated in the new grading system. In the present study, we validated the prognostic role of TGP5 in the new classification. METHODS: We retrospectively reviewed the records of 1396 patients with localized GS 6-8 PC (pT2-3N0M0) who underwent radical prostatectomy at our institution between 2005 and 2014. After excluding patients who received neoadjuvant or adjuvant therapy, or had incomplete pathological or follow-up data, 1229 patients were included in the final analysis. The Kaplan-Meier method was used to estimate and compare the probabilities of biochemical recurrence (BCR). Cox regression models were used to investigate associations between variables and the risk of BCR. RESULTS: Of 732 GS 7 patients, 75 (10.2%) had a TGP5. The BCR-free survival rate for men with TGP5 was significantly worse than for those without TGP5 (P<0.001). In multivariate Cox regression analyses for GS 7 PC, TGP5 was a significant predictor of BCR (hazard ratio 1.750, P=0.027). When the total cohort was stratified into four grade groups according to the new classification, group 2 with TGP5 had a BCR risk comparable to group 3, and group 3 with TGP5 behaved like group 4. CONCLUSIONS: Our study shows that TGP5 increased the BCR risk after RP in GS 7 PC. Moreover, we demonstrated that the presence of a TGP5 in GS 7 upgraded the BCR risk to one comparable with the next higher category under the new classification. These findings support incorporating TGP5 into GS 7 to aid with future risk assessment and follow-up scheduling for PC.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Jang WS, Yoon CY, Kim MS, et al. The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer. Prostate Cancer Prostatic Dis. 2016. PMID: 27845330. doi:10.1038/pcan.2016.55

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。